Medicare Rules Increase Out-of-Pocket Costs Of Multiple Sclerosis Drugs

Health Care Finance News
08 Feb, 2019 ,

According to a new research, Multiple Sclerosis Patients are facing extremely high treatment costs due to complicated insurance policies. The authors added that these elevated prices benefit those in the drug distribution channel including drug companies. The researchers concluded that certain changes are required to reduce total spending for beneficiaries.